Design, Synthesis, and Antitumor Activity of Erlotinib Derivatives

Nineteen erlotinib derivatives bearing different 1,2,3-triazole moieties were designed, synthesized, and evaluated for their potential against different cancer cell lines. The structures of the synthesized compounds were confirmed via1H NMR, 13C NMR, and HR MS. Preliminary antitumor activity assay r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Long-fei Mao, Zhen-Zhen Wang, Qiong Wu, Xiaojie Chen, Jian-Xue Yang, Xin Wang, Yue-Ming Li
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2022-04-01
Saila:Frontiers in Pharmacology
Gaiak:
erlotinib
EGFR
anticancer
drug-resistant cancer cell lines
1,2,3-triazole
Sarrera elektronikoa:https://www.frontiersin.org/articles/10.3389/fphar.2022.849364/full
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak